Daily news summaryTop News
Health & Fitness
Reuters: Health 1 hour 26 min ago
- Roche tablets are seen positioned in front of a displayed Roche logo in this picture illustration, January 22, 2016.
- Roche first launched the drug in India in 2002 and sells it for about 75,000 rupees ($1,170) for a 440 mg vial.
- "Roche adheres to all applicable laws and regulations in countries where it operates," Roche spokeswoman Shilpika Das said in a statement.
- Roche, which has been engaged in a legal tussle with Biocon and Mylan since 2014, has the option of filing a petition to contest the order, the lawyer added.
- In their complaint, Biocon and Mylan allege Roche wrote to doctors, hospitals, and state and federal regulators, misleading them about the safety of efficacy of the biosimilar versions.
Reuters: Health 1 hour 39 min ago
- Most worryingly, the researchers said at a briefing in London, the nanoparticles tend to build up in damaged blood vessels of people who already suffer from coronary heart disease – the condition that causes heart attacks and make it worse.
- Experts have long known that air pollution carries serious health risks and can trigger fatal heart attacks and strokes.
- According to the World Health Organization, outdoor air pollution in both cities and rural areas was estimated to cause 3.0 million premature deaths worldwide in 2012.
- They found the nanoparticles can migrate from the lungs into the bloodstream within 24 hours and are still detectable three months later.
- The researchers also analyzed surgically removed plaques from people at high risk of stroke and found that the nanoparticles tended to accumulate in the fatty plaques that grow inside blood vessels and cause heart attacks and strokes.
Reuters: Health 2 hours 33 min ago
- The British Union flag and the European Union flag are seen flying behind a clock in the City of London, Britain, January 16 , 2017.
- "We will do clinical trials in the UK, but the question is what will be the process for getting UK approval?"
- Officials say relations between regulatory bodies after Britain leaves the EU is a matter for Brexit negotiations in the runup to the divorce scheduled for March 2019.
- One option might be to agree special relationships with certain EU regulatory systems, either on a transitional or longterm basis.
- Currently, for example, drugmakers in the European Economic Area, or single market, can tap the entire market of 500 million potential patients with a single EU marketing approval.
Reuters: Health 3 hours 36 min ago
- FILE PHOTO: The logo of AstraZeneca is seen on medication packages in a pharmacy in London April 28, 2014.
- AstraZeneca had previously said it expected results in the first half of 2017.
- A company spokeswoman said the delay was because the trial had not yet observed enough clinical events in patients.
- Investor attention is focused primarily on giving the drug combination to previously untreated, or firstline, patients.
- Results from the closely watched MYSTIC trial in this much larger patient group are expected midyear.
Reuters: Health 6 hours 46 min ago
- In preclinical studies with lambs, the researchers were able to mimic the womb environment and the functions of the placenta, giving premature offspring a crucial opportunity to develop their lungs and other organs.
- At that age, a human baby weighs little more than 500 grams, its lungs are not able to cope with air and its chances of survival are low.
- "This system is potentially far superior to what hospitals can currently do for a 23weekold baby born at the cusp of viability," Flake said.
- The scientists made amniotic fluid in their lab and set up the system so that this flowed into and out of the bag.
- We simulate that environment ... allowing the lungs and other organs to develop while supplying nutrients and growth factors," he said.
Reuters: Health 16 hours 7 min ago
- Only one in 10 people would refuse to provide their sexual orientation, researchers found.
- One nurse said sexual orientation is nobody's business if the patient comes in for a cold or a cut.
- Based on the national survey, about 78 percent of healthcare providers thought patients would refuse to provide their sexual orientation.
- That reluctance may be tied to past studies showing bisexual individuals face more difficulty with their sexual orientation than other sexual minorities, the researchers write.
- Haider and colleague recently finished a study in which they tested ways of asking patients about sexual orientation.
Reuters: Health 16 hours 26 min ago
- They were just as likely as nontransgender children to say their gender as grownups would be the same as their gender in preschool.
- Transgender children did differ from their cisgender peers when asked about their gender as babies.
- Olson's team isn't sure why transgender children view their gender in infancy as different from their gender in preschool.
- The new study shows transgender children demonstrate the same developmental gender hallmarks as children who are not transgender, she said.
- "So this paper, like our past study, shows that from the perspective of the child's identified gender, these sociallytransitioned transgender children look just like most other kids," said Olson.
WebMD Health 17 hours 35 min ago
- TUESDAY, April 25, 2017 (HealthDay News) The U.S. Food and Drug Administration on Tuesday posted warning letters to 14 companies that are selling more than 65 fake cancer treatments.
- They're most commonly marketed and sold without FDA approval on websites and social media platforms, the FDA announcement of its action said.
- Consumers should be wary of certain phrases often used in the marketing of these treatments: "treats all forms of cancer," "miraculously kills cancer cells and tumors," "shrinks malignant tumors," "selectively kills cancer cells," "more effective than chemotherapy," "attacks cancer cells, leaving healthy cells intact," and "cures cancer."
- The FDA advises patients to always discuss cancer treatment options, including experimental drugs, with a licensed health care provider.
- Unproven cancer treatments for pets are also common, according to the FDA. "Increasingly, bogus remedies claiming to cure cancer in cats and dogs are showing up online.
WebMD Health 17 hours 35 min ago
- Some opioidrelated deaths may be missed when people die from pneumonia and other infectious diseases spurred on by drug abuse.
- That means a number of drugrelated deaths are not being counted, since surveillance systems mainly track overdose deaths.
- More than half of a series of drugrelated unexplained deaths in Minnesota between 2006 and 2015 listed pneumonia as the cause of death, Hall and her colleagues found.
- Twentytwo of these 59 unexplained drugrelated deaths involved toxic levels of opioids.
- And thus it's not going to get picked up in opioid surveillance," Hall said.
Reuters: Health 18 hours 5 min ago
- After two years, children at the schools with modified playgrounds were about 33 percent more likely to report pushing and shoving during recess than kids at schools with traditional playgrounds, researchers report in Pediatrics.
- After one year, parents of kids who had modified playgrounds were almost twice as likely to say kids had happy relationships with other students.
- But teachers did report more physical bullying and deliberate exclusion with modified playgrounds.
- The main limitation of the study is that bullying is difficult to assess, the authors note.
- Cora Collette Breuner, a researcher at Seattle Children’s Hospital and the University of Washington who wasn’t involved in the study.